OpenAI Launches GPT-Rosalind for Life Sciences Research and Expands Codex Capabilities

OpenAI introduced GPT-Rosalind, a specialized model targeting life sciences research for drug discovery acceleration, while expanding its Codex desktop app with autonomous computer task execution, memory recall across sessions, and image generation with gpt-image-1.5. The company now generates $2 billion in monthly recurring revenue.